We define multiple mechanisms by which commensals protect against or worsen Clostridioides difficile infection.
Introduction
commensal colonization on pathogen biomass, metabolomic analyses evaluated the nutrient content available to support C. difficile growth and metabolism ( Fig. 2 ; Supplemental Data Files SDF1-2, Supplemental Text).
Germfree cecal contents were significantly enriched for multiple classes of fermentable amino acids (SDF_2.11, 2.24) and carbohydrates (SDF2.9, 2.12, 2.25), including sugar alcohols of dietary origin with poor absorption from mouse and human gut (28) , and multiple purines and pyrimidines (Figs. 2A-G, SDF_2. 17-2.19 ).
In the absence of colonizing microbiota SCFA were absent (Fig. 2G ).
Monoclonization with CSAR or with CBI markedly changed the luminal environment prior to C. difficile's introduction. CSAR-monocolonization enriched multiple amine-containing carbon sources (Fig 2A, top) , including Stickland donor amino acids (SDF_2.24), additional fermentable amino acids (SDF_2.11) including cysteine, glutamate and asparate, which C. difficile can ferment in non-Stickland reactions (11) , g-glutamyl-amino acids (SDF_2.8), which originate from microbial metabolism and host amino acid transport (29) , and di-and polyamines (SDF_2.3). Among these sources, branched chain amino acids increased >2-3-fold (Fig. 2C) , and ornithine >16-fold over germfree levels (Fig. 2D ).
Among carbohydrate sources, CSAR depleted lumenal fructose, left mannitol/sorbitol levels unchanged and enriched levels of amino sugars, including ones originating from host glycoconjugates (Fig. 2B ). CSARmonocolonization depleted multiple purines and pyrimidines (SDF_2. 17-2.19 ) with >10-fold increases in 1methylhypoxanthine and 1-methyladenine, metabolites reported in other purine-fermenting Clostridia (Fig. 3E ; (30) . Colonization also promoted substantive increases in 3-ureidopropionate, a metabolite of microbial uracil metabolism, and >10-fold increase in beta-alanine which can originate from decarbamoylation of 3ureidopropionate (31) ( Fig 3E; SDF_2.19 ). Primary SCFA fermentation metabolites included acetate and butyrate (Fig. 2G) .
In contrast, CBI-monocolonization depleted polyamines, and Stickland acceptor and other fermentable amino acids ( Fig. 2A, middle) , consuming >70% of proline, >50% of glycine and >50% of threonine ( Fig. 2D ).
CBI produced abundant 5-amino-valerate ( Fig. 2F ) from proline, and isocaproate from reductive leucine Stickland reactions (32) (Fig. 2G ). From Stickland oxidative reactions, branched-SCFAs isobutyrate, isovalerate and 2-methylbutyrate were produced from branched-chain amino acids ( Fig. 2G ) and multiple aromatic amino acid metabolites from phenylalanine, tyrosine and tryptophan ( Figs. S2A-B ).
Among carbohydrates, CBI consumed >50% of fructose, left sugar alcohol levels unchanged ( Fig 2B; SDF_2. 25) , and produced acetate and propionate but no detectable butyrate ( Fig 2G) . CBI-monocolonization depleted multiple luminal pyrimidines and xanthosines (SDF_2. 17-2.19) , and substantively increased levels of 1-methylhypoxanthine and 1-methyladenine ( Fig 2E) . 3-ureidopopionate increased to a lesser extent that seen in CSAR-monocolonized mice, and without increased levels of beta-alanine ( Fig 3E; SDF_2.19 ).
C. difficile-monocolonzied mice demonstrated the broadest depletion of carbohydrate and aminecontaining carbon sources (Fig 2A, bottom) . The pathogen actively depleted Stickland acceptor-( Fig 2D) , gglutamyl-(SDF_2. 8) , and other fermentable amino acids (SDF_2.11), consuming >70% of proline ( Fig. 2D) , with concomintant increase in 5-aminovalerate ( Fig. 2F) , and consuming >70% of threonine and >50% of glycine (Figs. 2F-G). g-glutamyl-and N-acetyl amino acid conjugates to proline, branched-chain amino acids, and polyamines were also depleted (SDF_2.8, 2.10, 2.3).
Hexoses, pentoses and sugar alcohols were depleted, including >99% of luminal sorbitol/mannitol and >80% of fructose ( Figs. 2A-B) . In contrast to CSAR-and CBI-monocolonization, C. difficile-monocolonization did not show substantive depletion of purine or pyrimidine carbon sources but produced detectable 3ureidopropionate ( Fig. 2E, SDF_2 . 17-2.19) .
C. difficile-monoclonization produced acetate ( Fig. 2G ), which arises from carbohydrate fermentation, Stickland glycine and alanine fermentation, Wood-Ljungdahl metabolism, and other cellular processes (11) , and the Stickland branched-SCFA metabolites isobutyrate, isovalerate, 2-methylbutyrate and isocaproate ( Fig. 2G ).
Aromatic amino acid and histidine metabolites specific to the pathogen's Stickland metabolism were also produced ( Fig. S2A-B , Supplemental Text).
By 20h of infection, and per rapidly deteriorating mucosal conditions, CSAR and C. difficile-co-colonized mice (Fig 2H, top) demonstrated further enrichment of Stickland donor, acceptor, and other fermentable amino acids ( Fig. 2C-D) . Levels of uracil increased >8-fold and 3-ureidopropionate >40-fold compared to C. difficilemonocolonized mice ( Fig. 3E; SDF_2.19 ). In contrast, CBI and C. difficile-co-colonized mice showed no differences in amine-containing carbon sources as compared to C. difficile-monoclonized mice ( Fig. 2C-D) . CBIspecific Stickland aromatic amino acid metabolites predominated in the co-coloinzed state, suggesting a dominance of CBI's Stickland metabolism (Figs. S2A-B, Supplemental Text). These findings illustrated CSAR's capacity to create a nutrient enriched environment for C. difficile while CBI depleted many preferred nutrients.
Microbial colonization also altered levels of many host-origin compounds and of microbial metabolites with potential host effects. All three species enriched levels of host primary bile acids, including ones with in vitro inhibitory effects on C. difficile germination, such as b-muricholate and chenodeoxycholate, and others with simulatory effects including cholate and taurocholate (33, 34) (Fig 2A; SDF_2.16 ). C. difficile-monocolonized mice produced 7-ketodeoxycholate, a secondary bile acid (Supplemental Text) from the pathogen's 7ahydroxysterol-dehydrogenase (35) . Though CSAR carries a 7a-HSDH homolog enzyme (Supplemental Text), comparable changes were not observed in mice. CBI-monocolonization increased many host-origin sphingosinecontaining compounds (SDF_2.22), while CBI-and CSAR-monocolonization each enriched compounds with host neurotransmitter activities, including metabolites with serotonergic, GABA-ergic or NMDA-ergic activites, or with additional anti-inflammatory properties such as ethanolamide endocannabinoids (Supplemental Text; SDF_2.1, 2.5) (36) . These molecules were further enriched with the severe mucosal damage from CSAR and C. difficile-co-colonization.
CBI and CSAR differentially modulate C. difficile gene expression in vivo.
Commensal alterations in lumenal nutrient composition drove global alterations in C. difficile gene expression (Figs. 3A-E, SDF_4-5). Pathway enrichment analyses of C. difficile-monocolonized mice at 20h of infection showed significant enrichment of genes for the transport and metabolism of simple carbohydrates including glucose, fructose, ribose and disaccharides (Figs. 3A, 3D, SDF_5.2, 5.5, 5.7-9, 5.13), dipeptides and oligopeptides (SDF_5.4), and Wood-Ljungdahl pathway genes for CO2 fixation to acetate (SDF_5.17). By 24h the pathogen up-regulated ethanolamine utilization genes (SDF_5.6), enabling capacity to use ethanolamine and amino-alcohol lipids released from damaged mucosa (14) .
With the amino acid and polyamine enrichment from CSAR-monocolonization, C. difficile in co-colonized mice up-regulated amino acid and polyamine transporters, Stickland reductases, particularly the proline and reductive leucine systems ( Fig. 3A ; Supplemental Text; SDF_5. 14, 5.16) , and pathways to convert CSARenriched ornithine to Stickland fermentable substrates. In this latter category, C. difficile enriched expression of genes converting ornithine to alanine, and constitutively expressed genes converting ornithine to proline (Figs. 3C, S3A), enabling ornithine's use in both oxidative and reductive Stickland reactions (37) . These effects cooccurred with CSAR's up-regulation of an arginine deiminase (ADI) fermentation pathway by 20h of C. difficile infection ( Fig. S3B ), including the acrD arginine:ornithine antiporter which exports the ornithine product of arginine fermentation, identifiying a cause for the significantly elevated ornithine in CSAR-monocolonized mice (38) . In constrast, CBI's ADI pathway was down-regulated at 20h of co-colonization with C. difficile, followed by up-regulation by 24h with expression of its ornithine cyclodeaminase (OCD) which converts ornithine to proline, potentially conserving a proline-convertible carbon source for its Stickland metabolism (Figs. 3C, S3C).
With CSAR-co-colonization C. difficile also up-regulated a hydantoinase ( Fig 3F, Supplemental Text) able to metabolize uracil to 3-ureidopropionate, given the significant enrichment of uracil in co-colonized mice ( Fig.   2E ).
With CBI-co-colonization ( Fig. 3D -E), the pathogen adapted its metabolism to available nutrients, showing enrichment of genes to transport and metabolize sugar alcohols (SDF_5.15), including mannitol and sorbitol utilization operons, disaccharides (SDF_5.5), and polysaccharides (SDF_5.11), carbon sources not utilized by CBI (26) . C. difficile also enriched expression of genes for the transport and metabolism of xanthines (30) concomitant with enrichment of these compounds during CBI-monoconolonization (SDF_5.18).
In the presence of either commensal, C. difficile down-regulated cobalamin biosynthesis genes (Figs.
3A-B, 3D-E; SDF_5.27), in addition to folate biosynthesis when co-colonized with CSAR (SDF_5.28), suggesting cross-feeding of these nutrients with co-colonization.
Commensal colonization profoundly altered the pathogen's cellular machinery. C. difficile genes associated with transcription, translation, and DNA replication were up-regulated with CSAR-co-colonization ( Fig. 3A-B ; SDF_5.20-5.23). In contrast, by 24h of infection in CBI-co-colonized mice, the pathogen profoundly down-regulated protein synthesis, including multi-gene systems for translation and ribosome production ( (20) , and cell wall turnover enzymes (SDF_5.24). In CSAR-co-colonized mice, C. difficile sporulation pathways (SDF_5.42) and oxidative stress responses including superoxide dismutase (sodA), catalase (cotG) and nitroreductases were enriched (SDF_5.40), as were genes for terpenoid backbone synthesis (SDF_5.35), compounds in the spore coat and that can also provide anti-oxidant activities (39) . In contrast, CBI-co-colonization showed depletion of diffocins (SDF_5. 39 S3D-G; SDF_6-7). These latter aspects of oxidative stress further modified electron transport and energy generating pathways for both commensals (Supplemental Text),
CBI protects against C. difficile mutants lacking the CodY and CcpA PaLoc metabolic repressors.
CcpA and CodY repress C. difficile toxin expression when intracellular pools of fructose 1,6 bis-phosphate, or branched-chain amino acids and GTP, respectively, indicate sufficient carbohydrate or Stickland fermentable substrates to support metabolism (13, 40) . Given CBI's alterations on the gut nutrient environment and reduction of toxin levels, we evaluated whether these regulators mediated CBI's host-protective effects. In contrast, DcodY-infected mice demonstrated better growth with CBI-co-colonization, while the double mutant grew poorly (Figs 4B, S4D). At 16h of infection the DcodY mutant showed comparable vegetative biomass in monocolonized and co-colonized states, and elevated spore biomass in CBI-co-colonzied mice. The
DcodY mutant showed higher toxin levels at 16h as compared to wild-type controls, though levels in CBI-cocolonized mice were 70% lower that in DcodY-monocolonized controls (Figs. 4C, S4E). However, from 16h to 24h, toxin levels fell >40-fold in CBI-co-colonized mice (Figs. 4D, S4E), in spite of the DcodY mutant's higher vegetative biomass at 24h in co-colonized mice (Figs. 4B, S4D). These findings illustrated CBI's capacity to modulate the pathogen's growth, toxin production, and host survival, even in the absence of the PaLoc CodY and CcpA repressors.
CBI bacteriotherapy rescues conventional mice from lethal infection.
To assess CBI's potential as a therapeutic intervention, clindamycin-treated conventional mice were orally challenged with 1,000 C. difficile spores, followed by gavage at the onset of symptomatic infection with 10 8 CFU of CBI or vehicle-only control ( 
Discussion
We demonstrate distinct mechanisms by which individual commensals modulate C. difficile's virulence in vivo.
These findings have important implications to prevent and treat this disease, whether with targeted bacteriotherapeutics, small molecules, or other interventions, and to avoid conditions that pre-dispose patients to adverse outcomes such as toxic megacolon and recurrent infections. Importantly, FMT preparations of uncharacterized microbial populations can contain both protective and disease-exacerbating species. Introduced species may exihibit different behaviors near-and longer-term in antibiotic-depleted versus intact microbiota.
The effects highlight the importance of leveraging mechanistic data to inform testing of patients and therapeutics for signals of efficacy and exacerbation, and to optimize defined microbial preparations for therapeutic effects.
Development and severity of C. difficile infection occurs as a function of the pathogen's biomass, toxin production, and duration to which host tissues are exposed to toxin. Using a tractable gnotobiotic infection model, we identified the remarkably protective effects of a single commensal species, C. bifermentans, against C. difficile, and capacity for another Clostridial species, C. sardiniense, to promote more rapidly severe disease. Upon C. difficile's introduction, commensal competition and nutrient availability impacted the pathogen's growth and induction of stress responses, including ones directly promoting toxin gene expression, and others such as diffocins and sporulation, that impacted cellular integrity and potential toxin release through TcdE-independent mechanisms. C. difficile-monocolonized mice up-regulated diffocin genes, loci induced through quorum-sensing mechanisms where lysis of a portion of the population can release intracellular toxin stores to promote host damage and release nutrients for surviving vegetative populations (20) . Sporulation also induced expression of cell wall hydrolases that lyse the mother cell. These mechanisms may enable abrupt and TcdEindependent release of intracellular toxin stores, a process known to occur in other toxigenic species such as Shigella and ETEC where antibiotics or induction of lysogenic phage can promote abrupt toxin release through cell disruption (23, 41) .
In response to CSAR's enrichment of amine-containing carbon sources C. difficile up-regulated multiple amino acid transporters, Stickland fermentation pathways, and genes to convert CSAR-enriched ornithine to Stickland-metabolizable substrates. Resulting biomass of C. difficile and CSAR expanded with the increased carrying capacity of the altered gut environment and, with further nutrient release from damaged tissues, created a positive-feedback loop for microbial growth and toxin production, resulting in a rapidly lethal infection. Notably, CSAR produces abundant butyrate, which has been shown to to induce toxin expression in vitro (18) , while others have suggested protective effects in vivo (42) . Our studies showed that millimolar levels of microbialorigin butyrate did not prevent severe infection, rather multiple microbial mechanisms were involved in modulating pathogen behaviors and resulting host outcomes.
Notably, CSAR and CBI possess arginine deminase fermentation pathways, genes that modulated very different effects in vivo on C. difficile's growth and pathogenesis ( Fig. 3C ). With CSAR, the commensal's export of ornithine provided a new nutrient source for C. difficile metabolism and growth. In contrast, CBI's ability to internally convert ornithine to proline supported its own Stickland metabolism, depriving the pathogen of this nutrient source, while potentially increasing its ability to compete with C. difficile. This example highlights the importance of defining signals of efficacy for microbiota-derived products at the level of the target molecules, microbial genes, and effects on other microbes and the host.
CBI further affected multiple aspects of C. difficile physiology to reduce the pathogen's growth and toxin production, factors that persisted in the absence of C. difficile's CodY and CcpA PaLoc repressors (40, 43) . As an active Stickland fermenter, CBI depleted amine-containing carbon sources and simple carbohydrates preferred by C. difficile, leaving sugar alcohols and more complex carbohydrates available. In response, C. difficile adjusted its metabolism for these carbon sources and for hypoxanthines enriched in CBImonocolonization. Notably, C. difficile's protein translation machinery was significantly repressed in vivo with CBI-co-colonization, as were cellular lytic systems including diffocins, sporulation, cell-wall turnover enzymes, and oxidative stress pathways ( Figure 6 ).
In vivo studies also illustrated pathogen and commensal population effects over the course of infection.
The focal nature of early gut damage suggests localized events that can rapidly spread to alter host, pathogen and commensal behaviors. All three microbial species expressed oxidative stress or detoxification systems with Interventional studies in antibiotic-treated conventional mice illustrated CBI's efficacy as an oral bacteriotherapeutic when administered after the onset of symptomatic infection. The single dose of clindamycin enriched multiple fermentable amino acid and carbohydrate sources, sources that were also enriched in GF and CSAR-monocolonized mice prior to C. difficile's introduction, supporting relevance of findings from germfree infection studies. These findings support a broader systems-level view for combinations of metabolizable carbon sources that create nutrient states conducive to C. difficile colonization and rapid growth, particularly given the pathogen's diverse carbon source metabolism and responses that enable adaption to different gut environments.
As in CBI-co-colonized mice, therapeutic administration of CBI to conventional mice reduced pathogen biomass, acute toxin levels, and prevented lethal infection. CBI-administration depleted additional fermentable cabon sources, which may have occurred through direct and indirect interactions between CBI and the recovering microbiota. CBI administration also improved recovery of host sphingosines and ethanolamide endocannabinoids that were depleted with clindamycin treatment. While these compounds may support the growth and metabolism of ethanolamine and lipid-metabolizing commensal species, effects of such changes on host physiology and inflammatory responses warrant further investigation.
In vivo, colonic stores of amino acids and carbohydrates originate from un-absorbed dietary, microbial or host-produced sources (45) . Mucins, in particular, are rich in host-produced carbohydrates, amino acids including threonine, which was consumed by all three species, and the primary Stickland acceptor amino acids proline, glycine and leucine (46) . While proline and glycine are consumed in the reductive Stickland pathways, leucine can be consumed in either the oxidative or reductive reactions. In combination, the Stickland acceptor amino acids can enable rapid pathogen growth (47), with increased risks for population crashes and induction of stress responses that can promote abrupt spikes in toxin release.
Stickland fermention is a hallmark of the metabolism of Cluster XI Clostridia, and occurs in other Clostridial clusters, notably Clostridium scindens (Cluster XIVa) which posseses machinery for the proline and glycine reductases but not for the reductive leucine pathway (Fig. S6 ). While conversion of pro-germination primary bile acids to germination-inhibitory secondary bile acids by C. scindens and other species has been hypothesized to mediate in vivo protection against C. difficile (48, 49) , we show more fundamental capacity of commensal species, singly or in aggregate, to rapidly change the gut nutrient environment and resulting host responses to direct C. difficile's growth, cellular metabolism, and virulence. Notably, the CBI and CSAR strains monocolonized in mice did not demonstrate 7a-hydroxysterol-dehydrogenase activity in the bile acid metabolomic signatures (Supplemental Text), further emphasizing their modulation of disease outcomes independently of microbial bile salt transformations.
Stickland-fermenting species represent <1% of the human gut microbiota. Our findings highlight the importance of these low-abundance members upon growth-promoting nutrients for C. difficile, and identify conditions that could be created by these and other species to modulate C. difficile's virulence. These conditions act in concert with the host's digestive functioning, immune status, and other co-morbid conditions (50) . Host and commensal effects may also explain why C. difficile genetic polymorphisms and effects identified in vitro do not necessarily reflect behaviors seen in vivo. Armed with refined mechanistic knowledge, findings establish a robust framework in which to develop therapeutics with targeted efficacy and improved safety for this disease. 
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Materials and Methods

Bacterial strains and culture conditions
Table S1 shows the bacterial strains and their in vitro culture conditions. For quantitation of C. difficile and commensal biomass, mouse cecal contents were collected into pre-weighed Eppendorf tubes with 0.5mL of pre-reduced PBS with 40mM cysteine (Sigma Chemical, St. Louis, MO) as a reducing agent. Tubes were weighed after adding material and transferred into a Coy anaerobic chamber (Coy Labs, Grass Lake, MI) at 37°C for serial dilutions with plating to selective C. difficile CHROMID agar (Biomérieux, Durham, NC) or Brucella agar (Becton Dickinson, Canaan, CT) for commensal quantitation. C. difficile colonies were counted at 48 hours of incubation and identified as large black colonies. For the DcodY DccpA double mutant, colonies were quantitated at 72 hours of incubation. Commensal colonies were counted after 24 hours of incubation. CSAR colonies were identified as small, round beta-hemolytic colonies. CBI were identified as opaque and larger round colonies.
Representative colonies were species-confirmed using rapid ANA panels (Remel, Lenexa, KS). For studies in conventional mice, pre-infection and post-clindamycin fecal pellets showed no positive colonies on CHROMID agar.
C. difficile spore preparations and counts were defined by exposing pre-weighed material to 50% ethanol for 60 minutes followed by serial dilution and plating to C. difficile CHROMID agar, as described (51) .
Vegetative cell biomass was calculated by subtracting the spore biomass from the total biomass and normalizing to the cecal mass. Data were evaluated in Prism 8.0 (GraphPad, San Diego, CA) for visualization and log-rank tests of significance among groups. A p value <0.05 was considered significant. Table S2 indicates plasmid vectors and primer sequences used to generate gene-deleted mutants in ATCC43255. Mutants were created using a newly developed Allele-Coupled Exchange (ACE) vector, derived from pMTL-SC7215, a codA-based "pseudosuicide" plasmid that replicates in the cells at a rate lower than that of the host chromosome (52) . The codA cassette was removed by inverse PCR and replaced with the RCd8-CD2517.1 type I toxin-antitoxin module from C. difficile 630 using NEBuilder HiFi DNA Assembly (NEB), yielding pMSR0 (53) . In this vector, the CD2517.1 toxin gene was placed under control of the Ptet inducible promoter and the Rcd8 antitoxin was expressed from its own promoter. For deletions, allelic exchange cassettes were designed to have approximately 900 bp of homology to the chromosomal sequence in both up-and downstream locations of the sequence to be altered. The homology arms were amplified by PCR from C. difficile strain ATCC43255 genomic DNA (Table S1 ) and purified PCR products were cloned into the PmeI site of pMSR0 using NEBuilder's HiFi DNA Assembly. pMSR0-derived plasmids were transformed into E. coli strain NEB10β and inserts verified by sequencing.
Construction of C. difficile codY, ccpA and double codY ccpA mutant strains
Plasmids were then transformed into E. coli HB101 (RP4) and transferred by conjugation into C. difficile ATCC43255 after a brief period of heat shock (54) . The procedure for allelic exchange follows that used for the codA-mediated allelic exchange method (52), except counter-selection is based on inducible expression of the CD2517.1 toxin gene. Transconjugants were selected on BHI supplemented with cycloserine (250 μg/ml), cefoxitin (25 μg/ml) and thiamphenicol (15 μg/ml), and then restreaked onto BHI agar with thiamphenicol (15 μg/ml). After 24h, faster-growing single-crossover integrants formed visibly larger colonies. Individual colonies were re-streaked to BHI + thiamphenicol (15 μg/ml) to ensure purity of the single crossover integrant. Purified colonies were then re-streaked to BHI plates containing 100 ng/ml of the non-antibiotic analog anhydrotetracycline (ATc) to select for cells in which the plasmid had excised. In the presence of ATc, cells in which the plasmid is still present will produce CD2517.1 at toxic levels and will not form colonies. Clones were then confirmed by PCR for the expected deletion.
Mouse Studies
All animal studies were conducted under an approved institutional IACUC protocol. Defined-colonization experiments were conducted in negative pressure BL-2 gnotobiotic isolators (Class Biologically Clean, Madison, WI). Conventional studies were conducted in OptiMice containment cages (Animal Care Systems, Centennial, CO). Mice were singly housed for all studies.
Gnotobiotic Mouse Colonization and Infection Studies
One week prior to infection with C. difficile equal ratios of 6-7 week old male and female gnotobiotic mice were gavaged with 1x10 8 CFU of C. bifermentans (CBI), C. sardiniense (CSAR), or sterile vehicle control, and allowed to colonize for 7 days prior to challenge with 1x10 3 of wild-type or mutant C. difficile spores. Fecal pellets from mice were cultured prior to infection to confirm association with the defined species, or maintenance of the GF state. Progression of disease was assessed via body condition scoring (55) and body mass measurements taken by ethylene-oxide sterilized, battery powered OHAUS scales (Thermo-Fisher, Waltham, MA). Mice were sacrificed at a BCS of 2-, or at defined timepoints at 7 days of commensal monocolonization or GF controls, and at 20, 24h or 14 days post-C. difficile challenge. For C. difficile mutant infection studies, timepoints at 16h and 24h post-challenge were collected. Cecal contents were collected for functional studies. The GI tract and internal organs were fixed in zinc-buffered formalin (Z-FIX, Thermo-Fisher, Waltham, MA) for histopathologic assessment. 
Conventional Mouse Infection Studies
Histopathologic Analyses
Formalin-fixed segments of small bowel, cecum and colon from GF or specifically-associated mice were paraffin embedded and 5um sections cut for staining with hematoxylin and eosin (H&E; Thermo-Fisher, Waltham, MA) as described (56) . Stained slides were visualized under a Nikon Eclipse E600 microscope (Nikon, Melville, NY) for assessments of toxin-mediated epithelial damage, as evidenced by cellular stranding and vacuolation, and to assess the natures of Inflammatory infiltrates, mucosal erosions, and tissue edema.
Toxin B ELISA
Cecal toxin B levels were quantified as described (57) . Briefly, microtiter plates were coated with 10ug/mL of 
Effects of Commensal Colonization on Toxin Function
The Quidel C. difficile cell culture functional toxin assay (58) 
Western blot for Toxin B Integrity
Cecal supernatants from mice at 20h of infection extracted and subjected to SDS-PAGE and transfer to PVDF membrane (PerkinElmer, Waltham, MA) as described (59) 
Metabolomic studies
For GF colonization studies cecal contents from 8 mice per group across 2 experimental replicates were harvested from GF mice at baseline, after 7 days of monocolonization with CBI or CSAR, and at 20h postinfection with C. difficile alone or with each commensal (6 groups, 48 mice total). For conventional studies, cecal contents were collected from 12 mice per group prior to clindamycin treatment, 24h post-clindamycin treatment, and at 30h post C. difficile challenge, at the height of symptomatic infection. Materials were snap frozen into preweighed tubes and weighed to determine mass of cecal contents. Global metabolomic screen of samples was performed by Metabolon (Raleigh, NC) with sample extraction and MALDI-TOF analyses as described (60, 61) .
Results were obtained as Original Scale mass spectrometry counts.
Quantification of Short Chain Fatty Acids (SCFA)
Volatile short chain fatty acids from specifically-associated mice were quantified as described (26) . In brief, acidified internal standards with 100 µL of ethyl ether anhydrous or boron trifluoride-methanol was added to 100ul of supernatant from homogenized cecal contents. Chromatographic analyses were carried out on an Agilent 7890B system with flame ionization detector (FID). Chromatogram and data integration was carried out using the OpenLab ChemStation software (Agilent Technologies, Santa Clara, CA). SCFA in samples were identified by comparing their specific retention times relative to the retention time in the standard mix.
Concentrations were determined and expressed as mM of each SCFA per gram of sample for the raw cecal/fecal material. The Agilent platform cannot discriminate between isovalerate and 2-methylbutyrate and thus reports these compounds out as a single peak and interpolated value.
Carbon Source Enrichment Analyses
A variation of pathway enrichment analysis (62) was used to evaluate carbon source availability and consumption in vivo. Curated carbon source groups, optimized to reflect carbon source metabolism of gut commensal species, was developed with review of primarily literature regarding anaerobic metabolism of carbohydrate, amino acid and other amine-containing compounds, lipids, aromatic compounds, purines and pyrimidines, vitamins, micronutrients and other input sources for microbial metabolism and growth. Additional sources of reviewed information included published maps of C. difficile's biochemical pathways (63, 64) and BioCyc and MetaCyc content for C. difficile strain CD630 (62) . A carbon source group required a minimum of 6 biochemicals for evaluation. For studies in GF mice, 506 biochemicals, of 787 identified by the Metabolon panel, 64.3% of the dataset, were curated into carbon source groups (SDF 1.1-1.2). For studies in conventional mice, 667 biochemicals of 858, 77.8% of the dataset, were curated into carbon source groups (SDF 9.1-9.2).
Mass spectrometry datasets were filtered to remove biochemicals with values <50,000 counts across all sample (<3% of biochemicals). Remaining zero-value data points were assigned a value of 25,000 to support calculation of Log2 fold-change between comparisons. Datasets were Log2 transformed for significance testing of each biochemical by Welch's T test and Benjamini-Hochberg multi-hypothesis correction (65, 66) . Thresholds 
Transcriptome Data Processing
Reference bacterial and mouse genomes for C. difficile ATCC43255 (NZ_CM000604.1) and C. bifermentans ATCC638 (NZ_AVNC01000001.1) were obtained from the PATRIC Genome Annotation service (71) and Mus musculus C57BL6/J (GCF_000001635.26) from the NCBI host genome reference consortium to map reads. A genome for CSAR was generated using the methods as described in Nudel, et al (72) by Illumina MiSeq and was annotated in PATRIC (73) .
Paired-end reads were quality filtered and trimmed then mapped to mouse and microbial genomes using Bowtie2 (74) using strict requirements for read orientation. The "--no-mixed" and "--no-discordant" flags were used to ensure that paired reads aligned to the same section of the genome in the expected orientation, respectively. Read pairs with a mapping quality <10, a measure of alignment uniqueness, were filtered. Reads aligning to >1 genome were flagged for subsequent analysis to identify potential sites of homology among genomes.
Mapped reads were assigned to gene features using HTSeq (75) with flags "--nonunique all" to allow reads mapping to multiple features to be called to account for polycistronic RNAs, and "-a 10" to set the minimum mapping quality score at 10, a measure of alignment uniqueness. The identity of unaligned reads was analyzed with Kraken2 (76) to confirm association of mice with the expected species. Supplemental Table 3 shows the total and average read counts mapped to C. difficile, CSAR, CBI, or mouse across experimental conditions and replicates.
HTSeq results from each experimental replicate were binned by species and formatted for DESeq2 analyses (77) . Gene features where no set of experimental replicates averaged more than 10 reads per replicate were filtered from further analysis (<3% of genes). A widely used DESeq2 analysis template was modified for differential expression analysis (https://gist.github.com/stephenturner/f60c1934405c127f09a6). Read data from all experimental replicates of a given organism were included for pairwise DESeq2 analyses to insure the same adjusted read counts and estimates of dispersion across pairwise comparisons. Volcano plots showing the log2 fold change and adjusted p value for all analyzed genes, and Pearson's correlation matricies for each microbial transcriptome are shown in Figures S9-S11. Table S4 shows the number genes and percent of gene features mapped into pathway categories for each microbe. For C. difficile, mappings leveraged multiple previously published gene-level and pathway annotations for CD630 (64, 78, 79) and the bacterial-based Riley schema to define microbial pathways and super-pathways (80) , with addition of pathways such as "Mucin Degradation" to describe anaerobe-host categories, or ones that were missing or partially annotated in public resources. An operon map of C. difficile genes was created from the BioCyc content for the CD630 strain (62) . Genes present in ATCC43255, but not CD630, were treated as single-cistron operons (SDF 3.1-3.2). PATRIC and PROKKA (81) annotation of the CSAR and CBI genomes were used to develop pathway maps for these species. Gene features in the commensals were also subjected to BLAST against the CD630 reference genome to provide additional annotation information. The annotated microbial gene features are shown in SDF 3. Table S3 shows the total and percentage of reads passing quality filtering that were assigned to each microbe, or to mouse, in addition to ambiguous reads and reads not mapping to any genome. 
Transcriptome Pathway Enrichment Analyses
Supplemental Tables
